Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2013
05/08/2013CN103097357A Pyrazole compound
05/08/2013CN103097354A Substituted benzamide compounds
05/08/2013CN103097352A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/08/2013CN103087045A Benzimidazole heterocyclic compound, pharmaceutical composition and application thereof
05/08/2013CN103087044A Method for preparing benzimidazole heterocyclic compound
05/08/2013CN103087043A Benzamide derivative resisting proliferative activity and pharmaceutical preparation thereof
05/08/2013CN103087024A Flavone alkylamine compounds as well as preparation method and application thereof
05/08/2013CN103086981A New compounds
05/08/2013CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor
05/08/2013CN103086953A Heterocyclic compound and organic light-emitting device including the same
05/08/2013CN103086949A Carbazole derivatives and organic light emitting diodes comprising the same
05/08/2013CN103086942A Heterocyclic compound and organic light-emitting diode comprising the same
05/08/2013CN101821236B Five-membered heterocyclic compound
05/08/2013CN101203509B Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
05/07/2013US8436183 Synthetic multimerizing agents
05/07/2013US8436175 Carboxamide bioisosteres of opiates
05/07/2013US8436170 Xanthene dyes comprising a sulfonamide group
05/07/2013US8436017 Beta-2-adrenoreceptor agonists
05/07/2013US8435998 Crystalline form of posaconazole
05/07/2013US8435984 Tertiary amine substituted peptides useful as inhibitors of HCV replication
05/07/2013US8435983 Conformationally restrained epothilone analogues as anti-leukemic agents
05/07/2013US8435976 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
05/07/2013CA2598460C Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
05/07/2013CA2551956C Selective estrogen receptor modulators for the treatment of vasomotor symptoms
05/02/2013WO2013062843A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
05/02/2013WO2013062075A1 Organic electroluminescence element, and material for organic electroluminescence element
05/02/2013WO2013062043A1 4-aminocarbazole compound and use of same
05/02/2013WO2013061850A1 Organic electroluminescence element, display device, and lighting device
05/02/2013WO2013061205A2 Chemical compounds
05/02/2013WO2013061005A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/02/2013WO2013060837A1 Synthesis of triazolopyrimidine compounds
05/02/2013WO2013060751A1 Novel pyrazine derivatives
05/02/2013US20130109715 6-Substituted isoquinolines and isoquinolinones
05/02/2013US20130109713 Antimicrobial agents
05/02/2013US20130109706 Quinazoline-based t cell proliferation inhibitors
05/02/2013US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein
05/02/2013US20130109686 Isoindolone m1 receptor positive allosteric modulators
05/02/2013US20130109685 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
05/02/2013US20130109682 Cyclic ether compounds useful as kinase inhibitors
05/02/2013US20130109678 Radioprotector compounds and methods
05/02/2013US20130109652 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/02/2013US20130109566 Pesticidal compositions and processes related thereto
05/02/2013CA2853097A1 Novel trpv3 modulators
05/02/2013CA2853062A1 Pyridine- sulfoximines as tyrosine kinase inhibitors
05/02/2013CA2852652A1 Synthesis of triazolopyrimidine compounds
05/02/2013CA2851930A1 Novel pyrazine derivatives
05/02/2013CA2850925A1 Chemical compounds
05/02/2013CA2849977A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
05/01/2013EP2586773A1 Synthesis of Triazolopyrimidine Compounds
05/01/2013EP2585437A2 Thioacetate compounds, compositions and methods of use
05/01/2013CN103080105A Use of dibenzofurans and dibenzothiophenes substituted by nitrogen-bonded five-membered heterocyclic rings in organic electronics
05/01/2013CN103080104A N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
05/01/2013CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders
05/01/2013CN103073539A 4-(substituted phenylamino)quinazoline derivative, and preparation method, pharmaceutical composition and application thereof
05/01/2013CN103073538A Application of 1,4-dihydropyridine derivative as NO fluorescent probe
05/01/2013CN103073513A 1-substituted-5-chlorine-2H-1, 2, 3-triazole-4-carboxylic acid derivative and preparation method thereof
05/01/2013CN103073502A Synthetic method for aromatic cyclourea spiral medicine template and application of template in antineoplastic drugs
05/01/2013CN101821246B Tetrazole-substituted aryl amide derivatives and uses thereof
05/01/2013CN101784531B 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
05/01/2013CN101679270B Dihydroquinone and dihydronaphthridine inhibitors of JNK
05/01/2013CN101657430B Organic compounds and their uses
04/2013
04/30/2013US8431573 Cyanopyrimidinones
04/30/2013US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes
04/30/2013CA2599425C Substituted gamma lactams as therapeutic agents
04/30/2013CA2595834C Pyrazolylaminopyridine derivatives useful as kinase inhibitors
04/30/2013CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors
04/25/2013WO2013059677A1 Compounds that modulate intracellular calcium
04/25/2013WO2013059666A1 Compounds that modulate intracellular calcium
04/25/2013WO2013059651A1 Bifunctional compounds
04/25/2013WO2013059119A1 Glucosylceramide synthase inhibitors and therapeutic methods using the same
04/25/2013WO2013058258A1 Bicyclic heterocyclic compound
04/25/2013WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes
04/25/2013WO2013058098A1 Organic electroluminescent element
04/25/2013WO2013057320A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
04/25/2013WO2013057251A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
04/25/2013WO2013005168A3 Cannabinoid receptor modulators
04/25/2013WO2012122340A8 Soluble guanylate cyclase activators
04/25/2013US20130102790 Fungicide n-cycloalkyl-n-bicyclimethylene-carboxamide derivatives
04/25/2013US20130102776 Anticancer agent
04/25/2013US20130102617 Method of treating diabetes, metabolic syndrome and obesity using phenylacetamide derivative
04/25/2013US20130102616 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
04/25/2013US20130102607 Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections
04/25/2013US20130102604 Novel cyclopropane indolinone derivatives
04/25/2013US20130102597 Compounds and methods for treating inflammatory and fibrotic disorders
04/25/2013US20130102468 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
04/25/2013US20130102462 Process for Producing Imine Compounds for Combating Invertebrate Pests
04/25/2013US20130099208 Condensed-cyclic compound, method for preparing the condensed-cyclic compound and organic light-emitting device including the condensed-cyclic compound
04/25/2013CA2853469A1 Compounds that modulate intracellular calcium
04/25/2013CA2852750A1 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
04/25/2013CA2852355A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
04/25/2013CA2851589A1 Bicyclic heterocyclic compound
04/24/2013EP2582695A1 Anthranilic acid diamide derivatives with cyclical side chains
04/24/2013EP2582692A1 Cyclohexyl-azetidinyl antagonists of ccr2
04/24/2013EP2582676A1 Tetrahydroquinoline amide m1 receptor positive allosteric modulators
04/24/2013EP2582432A1 Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection
04/24/2013EP2004606B1 Substituted enaminocarbonyl compounds
04/24/2013CN103068823A Method for producing epoxy compound having cyanuric acid skeleton
04/24/2013CN103068822A Epoxy compound with nitrogen-containing ring
04/24/2013CN103068821A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
04/24/2013CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 694